|
I'm guessing because it's such a new prognosis factor to help with treatment? There really isn't any her2+ standard of care differences that I've seen yet (herceptin is still under study), expect maybe that Adriamyicin seem to work a bit better than some other chemos. I'll bet in 1-2 years it will be added to all of those sites.
|